Key Biologics and Cascade Regional Blood Services Partner on Leukapheresis Collections MEMPHIS, Tenn. and TACOMA, Wash., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Key Biologics LLC and Cascade Regional Blood Services (CRBS) today announced a multi-year agreement to provide researchers in...

Key Biologics and Blood Centers of America Partner to Advance Cell Therapy and Regenerative Medicine MEMPHIS, Tenn. and WEST WARWICK, R.I., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC and Blood Centers of America (BCA) today announced an agreement to formalize their existing business...

Key Biologics Accelerates CAR-T Research with New Leukaphereses Offerings MEMPHIS, Tenn. and MONTREAL, May 03, 2018 (GLOBE NEWSWIRE) -- Key Biologics LLC, a provider of biological raw materials and services for manufacturing cell-based therapeutics, today announced the...

Global Market for Stem Cell Techs to Achieve Double-Digit Growth Rate WELLESLEY, Mass., March 29, 2018 (GLOBE NEWSWIRE) -- Stem cell technology has already produced many significant products in terms of therapeutics, creating numerous opportunities within the market....